http://www.laf.org/site/c.beIKLOOrGpF/b.507293/k.6E55/Andrew_C_von_Eschenbach_MD.htm In 1976, Dr. von Eschenbach obtained a fellowship in...
FDA director Andrew C. von Eschenbach, M.D two-time cancer survivor? three-time cancer survivor? might choose to save his own life. If cervical...
FDA director will be remembered for his action on Provenge: 1) Approved, verified later with IMPACT. He is the man, brave, has courage, saved...
There won't be a clear approval, or rejection, here is two possible decisions on May 15. 1) Provenge will be approved, but DNDN must complete...
Vioxx problem? Use short term data to predict long term effect. All cancer drug trials use short term data to predict long term effect....
1) Long term survival rate should be end point for all cancer trials automatically. All needed is a few investors pick up phone talk to their...
Does anyone know when FDA makes decision? 4:55pm May 15?
Approval Letter $9 (50%) Approved $27 (50%) If its a plain approval letter the invest bank s will buy at $7. If the approval letter takes...
Median Survival (month) Benefit is 4.5 months. The Median Survival (month) is flawed, because nothing will change once half the patients died.
The article mentioned: 26% vs 15% less serious patients in the treatment group. OK OK, the difference is 11%, and we assume the extra 11%...
All existing cancer trials are flawed, the long term survival rate should have the final say when it's available, period. All clinical trials...
Let's cool down a little bit: The FDA panel decision basically put DNDN at least in a position which has two very large successful Phase II...
Approval letter with detailed condition will make to stock stay above $10
In the worst case... DNDN will get an approval letter that put DNDN around $6. On May 15, the 7.5 puts would worth $1.5, let assign 40%...
Refresh allows you to pass: Just made to top 20 (44/65)
There should be option to pass..., but after a few trials, it convinces me TA works
What's day was yesterday?
Turn on radio
I paid $100 to get futures intraday data for last few years, used very simple information extraction method, I can see the data wiggling...
They do a lot of automated trading, at least the automated trading didn't make enough. I am sure they back-tested a lot of data, the problem...
Separate names with a comma.